Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.
 BACK TO LIST

Laboratory Report

Patient
Name: Quesada, Anastasia
DOB: 09-APR-1955 (Age: 70)
Gender: female
Address:
Pasaje Eli Madrigal 26
26001 La Rioja (Spain)
ID: 7881-246905-0 (ECI)
Report
Date: 10-JUL-2020
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Consultorio Médico
Calle de los Donantes de Sangre 3
26140 Lardero (Spain)
Specimen
Collected: 10-JUL-2020

Chemistry

Test 10-JUL-2020 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 6.0 H 4.8 - 5.9 %
Glucose [Mass/volume] in Blood 89.5 70 - 100 mg/dL
Urea nitrogen [Mass/volume] in Blood 11.1 7 - 20 mg/dL
Creatinine [Mass/volume] in Blood 0.7 0.6 - 1.3 mg/dL
Calcium [Mass/volume] in Blood 10.1 8.6 - 10.3 mg/dL
Sodium [Moles/volume] in Blood 140.7 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 4.2 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Blood 109.3 98 - 110 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 25.4 22 - 29 mmol/L
Cholesterol [Mass/volume] in Serum or Plasma 179.4 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 115.0 0 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 128.4 H 0 - 100 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 28.0 L 40 - 60 mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows mildly elevated HbA1c, indicating suboptimal long-term glucose control. Lipid profile reveals high LDL and low HDL cholesterol, increasing cardiovascular risk. Other parameters, including renal function, electrolytes, and triglycerides, are within normal limits. Recommend further evaluation and management of dyslipidemia and glycemic control.